المؤلفون: Faouzi Djebbari (6004379), Alexandros Rampotas (11933847), Fotios Panitsas (11933850), Wen Yuen Lim (11933853), Charlotte Lees (5864870), Ismini Tsagkaraki (11933856), Ana Rita Gomes (9089092), Steve Prideaux (11933859), Lucia Chen (7349012), Catherine Prodger (11933862), Akhil Khera (11933865), Nicola Gray (1590448), Lauren Ellis (11933868), Gina Sangha (11933871), Toby A. Eyre (8479401), Sally Moore (6078818), Jaimal Kothari (6078821), Karthik Ramasamy (795392)

مصطلحات موضوعية: Medicine, Physiology, Pharmacology, Biotechnology, Developmental Biology, Cancer, Mental Health, Hematology, Infectious Diseases, overall response rate, focus towards reducing, enable meaningful comparisons, 89 &# 8211, clinical trial setting, clinical outcomes included, patients treated exclusively, proven prognostic values, higher incidence rate, based vcd therapy, revised myeloma co, worse ae outcomes, individualise treatment decisions, 61 &# 8211, myeloma risk profile, shorter median os, clinical outcomes according, frail patients compared, treating frail patients, os ), progression

Relation: https://figshare.com/articles/figure/Inclusion_exclusion_in_the_cohort_and_frailty_score_categories_/18175683

الاتاحة: https://doi.org/10.1371/journal.pone.0262388.g001

المؤلفون: Faouzi Djebbari (6004379), Alexandros Rampotas (11933847), Fotios Panitsas (11933850), Wen Yuen Lim (11933853), Charlotte Lees (5864870), Ismini Tsagkaraki (11933856), Ana Rita Gomes (9089092), Steve Prideaux (11933859), Lucia Chen (7349012), Catherine Prodger (11933862), Akhil Khera (11933865), Nicola Gray (1590448), Lauren Ellis (11933868), Gina Sangha (11933871), Toby A. Eyre (8479401), Sally Moore (6078818), Jaimal Kothari (6078821), Karthik Ramasamy (795392)

مصطلحات موضوعية: Medicine, Physiology, Pharmacology, Biotechnology, Developmental Biology, Cancer, Mental Health, Hematology, Infectious Diseases, overall response rate, focus towards reducing, enable meaningful comparisons, 89 &# 8211, clinical trial setting, clinical outcomes included, patients treated exclusively, proven prognostic values, higher incidence rate, based vcd therapy, revised myeloma co, worse ae outcomes, individualise treatment decisions, 61 &# 8211, myeloma risk profile, shorter median os, clinical outcomes according, frail patients compared, treating frail patients, os ), progression

Relation: https://figshare.com/articles/figure/Overall_survival_OS_by_frailty_frail_vs_intermediate_or_fit_46_months_vs_not_reached_HR_1_94_95_CI_0_89_4_2_p_0_094_/18175686

الاتاحة: https://doi.org/10.1371/journal.pone.0262388.g002

المؤلفون: Faouzi Djebbari (6004379), Alexandros Rampotas (11933847), Fotios Panitsas (11933850), Wen Yuen Lim (11933853), Charlotte Lees (5864870), Ismini Tsagkaraki (11933856), Ana Rita Gomes (9089092), Steve Prideaux (11933859), Lucia Chen (7349012), Catherine Prodger (11933862), Akhil Khera (11933865), Nicola Gray (1590448), Lauren Ellis (11933868), Gina Sangha (11933871), Toby A. Eyre (8479401), Sally Moore (6078818), Jaimal Kothari (6078821), Karthik Ramasamy (795392)

مصطلحات موضوعية: Medicine, Physiology, Pharmacology, Biotechnology, Developmental Biology, Cancer, Mental Health, Hematology, Infectious Diseases, overall response rate, focus towards reducing, enable meaningful comparisons, 89 &# 8211, clinical trial setting, clinical outcomes included, patients treated exclusively, proven prognostic values, higher incidence rate, based vcd therapy, revised myeloma co, worse ae outcomes, individualise treatment decisions, 61 &# 8211, myeloma risk profile, shorter median os, clinical outcomes according, frail patients compared, treating frail patients, os ), progression

Relation: https://figshare.com/articles/figure/Progression-free_survival_PFS_by_frailty_frail_vs_intermediate_or_fit_11_8_vs_9_9_months_HR_0_99_95_CI_0_61_1_61_P_0_982_/18175692

الاتاحة: https://doi.org/10.1371/journal.pone.0262388.g003

المؤلفون: Faouzi Djebbari (6004379), Alexandros Rampotas (11933847), Fotios Panitsas (11933850), Wen Yuen Lim (11933853), Charlotte Lees (5864870), Ismini Tsagkaraki (11933856), Ana Rita Gomes (9089092), Steve Prideaux (11933859), Lucia Chen (7349012), Catherine Prodger (11933862), Akhil Khera (11933865), Nicola Gray (1590448), Lauren Ellis (11933868), Gina Sangha (11933871), Toby A. Eyre (8479401), Sally Moore (6078818), Jaimal Kothari (6078821), Karthik Ramasamy (795392)

مصطلحات موضوعية: Medicine, Physiology, Pharmacology, Biotechnology, Developmental Biology, Cancer, Mental Health, Hematology, Infectious Diseases, overall response rate, focus towards reducing, enable meaningful comparisons, 89 &# 8211, clinical trial setting, clinical outcomes included, patients treated exclusively, proven prognostic values, higher incidence rate, based vcd therapy, revised myeloma co, worse ae outcomes, individualise treatment decisions, 61 &# 8211, myeloma risk profile, shorter median os, clinical outcomes according, frail patients compared, treating frail patients, os ), progression

Relation: https://figshare.com/articles/dataset/Baseline_patient_disease_and_treatment_characteristics_for_the_total_cohort_and_for_the_different_MRP_subgroups_frail_vs_intermediate_or_fit_/18175695

الاتاحة: https://doi.org/10.1371/journal.pone.0262388.t001

المؤلفون: Faouzi Djebbari (6004379), Alexandros Rampotas (11933847), Fotios Panitsas (11933850), Wen Yuen Lim (11933853), Charlotte Lees (5864870), Ismini Tsagkaraki (11933856), Ana Rita Gomes (9089092), Steve Prideaux (11933859), Lucia Chen (7349012), Catherine Prodger (11933862), Akhil Khera (11933865), Nicola Gray (1590448), Lauren Ellis (11933868), Gina Sangha (11933871), Toby A. Eyre (8479401), Sally Moore (6078818), Jaimal Kothari (6078821), Karthik Ramasamy (795392)

مصطلحات موضوعية: Medicine, Physiology, Pharmacology, Biotechnology, Developmental Biology, Cancer, Mental Health, Hematology, Infectious Diseases, overall response rate, focus towards reducing, enable meaningful comparisons, 89 &# 8211, clinical trial setting, clinical outcomes included, patients treated exclusively, proven prognostic values, higher incidence rate, based vcd therapy, revised myeloma co, worse ae outcomes, individualise treatment decisions, 61 &# 8211, myeloma risk profile, shorter median os, clinical outcomes according, frail patients compared, treating frail patients, os ), progression

Relation: https://figshare.com/articles/dataset/Reasons_for_discontinuation_of_first_line_VCD_myeloma_therapy_in_the_total_cohort_in_MRP_subgroups_frail_vs_intermediate_or_fit_and_in_co-morbidity_subgroups_/18175701

الاتاحة: https://doi.org/10.1371/journal.pone.0262388.t002

المؤلفون: Faouzi Djebbari (6004379), Alexandros Rampotas (11933847), Fotios Panitsas (11933850), Wen Yuen Lim (11933853), Charlotte Lees (5864870), Ismini Tsagkaraki (11933856), Ana Rita Gomes (9089092), Steve Prideaux (11933859), Lucia Chen (7349012), Catherine Prodger (11933862), Akhil Khera (11933865), Nicola Gray (1590448), Lauren Ellis (11933868), Gina Sangha (11933871), Toby A. Eyre (8479401), Sally Moore (6078818), Jaimal Kothari (6078821), Karthik Ramasamy (795392)

مصطلحات موضوعية: Medicine, Physiology, Pharmacology, Biotechnology, Developmental Biology, Cancer, Mental Health, Hematology, Infectious Diseases, overall response rate, focus towards reducing, enable meaningful comparisons, 89 &# 8211, clinical trial setting, clinical outcomes included, patients treated exclusively, proven prognostic values, higher incidence rate, based vcd therapy, revised myeloma co, worse ae outcomes, individualise treatment decisions, 61 &# 8211, myeloma risk profile, shorter median os, clinical outcomes according, frail patients compared, treating frail patients, os ), progression

Relation: https://figshare.com/articles/dataset/Response_rates_to_first_line_VCD_myeloma_therapy_in_the_total_cohort_in_MRP_subgroups_frail_vs_intermediate_or_fit_and_in_co-morbidity_subgroups_/18175704

الاتاحة: https://doi.org/10.1371/journal.pone.0262388.t003

المؤلفون: Faouzi Djebbari (6004379), Alexandros Rampotas (11933847), Fotios Panitsas (11933850), Wen Yuen Lim (11933853), Charlotte Lees (5864870), Ismini Tsagkaraki (11933856), Ana Rita Gomes (9089092), Steve Prideaux (11933859), Lucia Chen (7349012), Catherine Prodger (11933862), Akhil Khera (11933865), Nicola Gray (1590448), Lauren Ellis (11933868), Gina Sangha (11933871), Toby A. Eyre (8479401), Sally Moore (6078818), Jaimal Kothari (6078821), Karthik Ramasamy (795392)

مصطلحات موضوعية: Medicine, Physiology, Pharmacology, Biotechnology, Developmental Biology, Cancer, Mental Health, Hematology, Infectious Diseases, overall response rate, focus towards reducing, enable meaningful comparisons, 89 &# 8211, clinical trial setting, clinical outcomes included, patients treated exclusively, proven prognostic values, higher incidence rate, based vcd therapy, revised myeloma co, worse ae outcomes, individualise treatment decisions, 61 &# 8211, myeloma risk profile, shorter median os, clinical outcomes according, frail patients compared, treating frail patients, os ), progression

Relation: https://figshare.com/articles/dataset/Univariate_UVA_and_multivariate_MVA_analyses_for_PFS_and_OS_/18175707

الاتاحة: https://doi.org/10.1371/journal.pone.0262388.t004

المؤلفون: Faouzi Djebbari (6004379), Alexandros Rampotas (11933847), Fotios Panitsas (11933850), Wen Yuen Lim (11933853), Charlotte Lees (5864870), Ismini Tsagkaraki (11933856), Ana Rita Gomes (9089092), Steve Prideaux (11933859), Lucia Chen (7349012), Catherine Prodger (11933862), Akhil Khera (11933865), Nicola Gray (1590448), Lauren Ellis (11933868), Gina Sangha (11933871), Toby A. Eyre (8479401), Sally Moore (6078818), Jaimal Kothari (6078821), Karthik Ramasamy (795392)

مصطلحات موضوعية: Medicine, Physiology, Pharmacology, Biotechnology, Developmental Biology, Cancer, Mental Health, Hematology, Infectious Diseases, overall response rate, focus towards reducing, enable meaningful comparisons, 89 &# 8211, clinical trial setting, clinical outcomes included, patients treated exclusively, proven prognostic values, higher incidence rate, based vcd therapy, revised myeloma co, worse ae outcomes, individualise treatment decisions, 61 &# 8211, myeloma risk profile, shorter median os, clinical outcomes according, frail patients compared, treating frail patients, os ), progression

Relation: https://figshare.com/articles/dataset/Toxicities_associated_with_VCD_therapy_in_the_total_cohort_/18175710

الاتاحة: https://doi.org/10.1371/journal.pone.0262388.t005

المؤلفون: Gonzalez Blanco, Mariafernanda, Rojas Pava, Sebastián

المساهمون: Mantilla Duran, William Armando, Barragan, Ana M., Munevar, Isabel, Educación Médica y en Ciencias de la Salud

المصدر: 1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

مصطلحات موضوعية: Neoadjuvant chemotherapy (NCT), HER2 (Human Epidermal Growth Factor Receptor-type2), Breast cancer, breast cancer, chemother, Analysis of clinical outcomes according to treatment with QTN in breast cancer, Análisis de desenlaces clínicos según tratamiento con QTN en Cáncer de seno, HER2 positive breast cancer treatment with QTN, HER2 (Factor de crecimiento epidérmico humano Receptor-type2), Tratamiento con QTN al cáncer mamario HER2 positivo, Investigaciones sobre el cáncer de mama en mujeres, Research on breast cancer in women, Quimioterapia neoadyuvante (QTN), Incidencia & prevención de la enfermedad

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6ba1dce86a745f864b669bd4a87437e
https://repository.urosario.edu.co/handle/10336/30978

المؤلفون: Vega Hernández, Paula Alejandra

المساهمون: De la Peña, Jairo, Pedraza Flechas, Ana María

المصدر: instname:Universidad del Rosario

مصطلحات موضوعية: Cáncer de mama triple negativo, Análisis de desenlaces clínicos según tratamiento y estadio de diagnóstico, Caracterización de tratamientos adyuvantes Neoadyuvantes en el tratamiento de cáncer de mama, Ginecología & otras especialidades médicas, Triple negative breast cancer, Analysis of clinical outcomes according to treatment and stage of diagnosis, Characterization of adjuvant and Neoadjuvant treatments in the treatment of breast cancer

وصف الملف: application/pdf

Relation: https://repository.urosario.edu.co/handle/10336/30939; https://doi.org/10.48713/10336_30939

الاتاحة: https://repository.urosario.edu.co/handle/10336/30939
https://doi.org/10.48713/10336_30939

المؤلفون: Rojas Pava, Sebastián, Gonzalez Blanco, Mariafernanda

المساهمون: Mantilla Duran, William Armando, Barragan, Ana M., Munevar, Isabel, Educación Médica y en Ciencias de la Salud

المصدر: instname:Universidad del Rosario

مصطلحات موضوعية: Investigaciones sobre el cáncer de mama en mujeres, Quimioterapia neoadyuvante (QTN), HER2 (Factor de crecimiento epidérmico humano Receptor-type2), Análisis de desenlaces clínicos según tratamiento con QTN en Cáncer de seno, Tratamiento con QTN al cáncer mamario HER2 positivo, Incidencia & prevención de la enfermedad, Breast cancer, chemother, Research on breast cancer in women, Neoadjuvant chemotherapy (NCT), HER2 (Human Epidermal Growth Factor Receptor-type2), Analysis of clinical outcomes according to treatment with QTN in breast cancer, HER2 positive breast cancer treatment with QTN

وصف الملف: application/pdf

Relation: https://repository.urosario.edu.co/handle/10336/30978; https://doi.org/10.48713/10336_30978

الاتاحة: https://repository.urosario.edu.co/handle/10336/30978
https://doi.org/10.48713/10336_30978